Figure 2From: Effect of erythropoietin-stimulating agent on uremic inflammationThe CRP levels of ESKD patients with and without ESA using at the initiation of renal replacement therapy. Significantly less CRP concentration was found in ESA user compared with non-user by using student’s t-test (0.42 ± 0.65 mg/dL vs. 0.61 ± 0.76 mg/dL). Solid line depicts the correlation coefficient by means of Pearson’s univariate regression analysis (r = −0.119, p = 0.0005).Back to article page